Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31
Closed -$584 3495
2025
Q4
$584 Buy
+31
New +$519 ﹤0.01% 3212
2025
Q3
Sell
-352
Closed -$6.88K 3398
2025
Q2
$6.88K Hold
352
﹤0.01% 2481
2025
Q1
$6.25K Hold
352
﹤0.01% 2516
2024
Q4
$7.54K Hold
352
﹤0.01% 2458
2024
Q3
$11K Hold
352
﹤0.01% 2296
2024
Q2
$5.47K Buy
+352
New +$4.25K ﹤0.01% 2480
2022
Q3
Sell
-10
Closed 3125
2022
Q2
$0 Sell
10
-9
-47% -$250 ﹤0.01% 3136
2022
Q1
$1K Sell
19
-8
-30% -$312 ﹤0.01% 2955
2021
Q4
$1K Buy
27
+13
+93% +$679 ﹤0.01% 2886
2021
Q3
$1K Sell
14
-6
-30% -$457 ﹤0.01% 2791
2021
Q2
$2K Buy
+20
New +$1.59K ﹤0.01% 2545
2019
Q3
Sell
-2
Closed 2101
2019
Q2
$0 Buy
+2
New +$64 ﹤0.01% 2041

Other funds holding CDNA

SignatureFD's CDNA Position: Q1 2026 in Review

SignatureFD sold out of CareDx (CDNA) in Q1 2026, closing a stake of 31 shares — an estimated $584 sold.

SignatureFD first reported a position in CDNA in Q2 2019 and held it in 12 quarters. The position peaked at $11K in Q3 2024. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • SignatureFD reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
  • SignatureFD sold 31 CareDx shares in Q1 2026, an estimated $584.
  • SignatureFD first reported a position in CareDx in Q2 2019 and held it in 12 quarters.
  • SignatureFD's CareDx position peaked at $11K in Q3 2024.
  • 191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.